Urology therapeutics Market Research Reports

"...... ort provides comprehensive information on the therapeutics under development for Aicardi-Goutieres Syndrome (AGS), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type......"

"...... provides comprehensive information on the therapeutics under development for Amino Acid Metabolism Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. Th......"

"...... tics under development for Barth Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the t......"

"...... ation on the therapeutics under development for Congenital Ichthyosis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pha......"

"...... pe. The report provides comprehensive information on the therapeutics under development for Hyperargininemia (Arginase I Deficiency), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Admini......"

"...... - Drugs in Development, 2021 provides an overview of the Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) pipeline landscape. The report provides comprehensive information on the therapeut......"

"...... richorrhexis Invaginata, Bamboo Hair) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair), complete with analysis by Stage......"

"...... yelinase Deficiency (Niemann-Pick Disease) Type A pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A, complete with a......"

"...... peutics under development for Alport Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of t......"

"...... > The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type II, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and M......"